tradingkey.logo

Penumbra Inc

PEN

263.120USD

-9.610-3.52%
Fechamento 09/15, 16:00ETCotações atrasadas em 15 min
10.25BValor de mercado
69.42P/L TTM
Mais detalhes de Penumbra Inc Empresa
Penumbra, Inc. is a healthcare company. The Company designs, develops, manufactures, and markets products and has a portfolio that addresses challenging medical conditions in markets with unmet need. It is focused on developing, manufacturing, and marketing products for use by specialist physicians and healthcare providers to drive improved clinical and health outcomes. It is focused on developing and building its portfolio of products, including its thrombectomy, embolization, access, and immersive healthcare technologies. Common conditions that the Company focuses on Pulmonary Embolism, Deep Vein Thrombosis, Peripheral Arterial Occlusion, Ischemic Stroke, Acute Coronary Syndrome, Clot associated with Arteriovenous Graft or Fistula, Aneurysm, and Hemorrhagic Stroke. The Company sells its products to healthcare providers primarily through its direct sales organization in the United States, Europe, Canada and Australia, as well as through distributors in select international markets.
Informações da empresa
Código da empresaPEN
Nome da EmpresaPenumbra Inc
Data de listagemSep 18, 2015
CEOMr. Adam Elsesser, J.D.
Número de funcionários4500
Tipo de títulosOrdinary Share
Fim do ano fiscalSep 18
EndereçoOne Penumbra Place
CidadeALAMEDA
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal94502
Telefone15109952486
Sitehttps://www.penumbrainc.com/
Código da empresaPEN
Data de listagemSep 18, 2015
CEOMr. Adam Elsesser, J.D.
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Adam Elsesser, J.D.
Mr. Adam Elsesser, J.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.02M
+1.21%
Dr. Arani Bose, M.D.
Dr. Arani Bose, M.D.
Director
Director
290.26K
-3.97%
Ms. Johanna Roberts
Ms. Johanna Roberts
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
52.28K
-1.13%
Mr. Lambert Shiu
Mr. Lambert Shiu
Chief Accounting Officer
Chief Accounting Officer
25.61K
-4.98%
Ms. Janet Leeds
Ms. Janet Leeds
Independent Director
Independent Director
5.49K
-1.06%
Ms. Bridget O'Rourke
Ms. Bridget O'Rourke
Independent Director
Independent Director
4.82K
-1.03%
Ms. Surbhi Sarna
Ms. Surbhi Sarna
Independent Director
Independent Director
3.15K
-1.84%
Ms. Maggie S. Yuen
Ms. Maggie S. Yuen
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Thomas C. (Tom) Wilder, III
Mr. Thomas C. (Tom) Wilder, III
Presiding Independent Director
Presiding Independent Director
--
--
Ms. Shruthi Narayan
Ms. Shruthi Narayan
President
President
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Adam Elsesser, J.D.
Mr. Adam Elsesser, J.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.02M
+1.21%
Dr. Arani Bose, M.D.
Dr. Arani Bose, M.D.
Director
Director
290.26K
-3.97%
Ms. Johanna Roberts
Ms. Johanna Roberts
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
52.28K
-1.13%
Mr. Lambert Shiu
Mr. Lambert Shiu
Chief Accounting Officer
Chief Accounting Officer
25.61K
-4.98%
Ms. Janet Leeds
Ms. Janet Leeds
Independent Director
Independent Director
5.49K
-1.06%
Ms. Bridget O'Rourke
Ms. Bridget O'Rourke
Independent Director
Independent Director
4.82K
-1.03%
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por EmpresaUSD
Nome
Receita
Proporção
Thrombectomy
226.54M
69.89%
Embolization and Access
97.60M
30.11%
Por RegiãoUSD
Nome
Receita
Proporção
United States
256.86M
79.24%
International
67.28M
20.76%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Thrombectomy
226.54M
69.89%
Embolization and Access
97.60M
30.11%
Distribuição de ações
Atualizado em: qua, 20 de ago
Atualizado em: qua, 20 de ago
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Fidelity Management & Research Company LLC
12.92%
The Vanguard Group, Inc.
9.88%
BlackRock Institutional Trust Company, N.A.
9.25%
T. Rowe Price Associates, Inc.
3.44%
State Street Global Advisors (US)
3.00%
Outro
61.51%
Investidores
Investidores
Proporção
Fidelity Management & Research Company LLC
12.92%
The Vanguard Group, Inc.
9.88%
BlackRock Institutional Trust Company, N.A.
9.25%
T. Rowe Price Associates, Inc.
3.44%
State Street Global Advisors (US)
3.00%
Outro
61.51%
Tipos de investidores
Investidores
Proporção
Investment Advisor
60.28%
Investment Advisor/Hedge Fund
22.54%
Hedge Fund
5.09%
Individual Investor
3.66%
Pension Fund
1.88%
Research Firm
1.69%
Sovereign Wealth Fund
1.18%
Bank and Trust
0.53%
Private Equity
0.08%
Outro
3.06%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
864
37.32M
95.72%
-2.83M
2025Q1
878
36.92M
95.33%
-3.44M
2024Q4
834
37.02M
96.10%
-3.78M
2024Q3
813
37.33M
96.12%
-2.93M
2024Q2
796
37.57M
96.93%
+395.13K
2024Q1
777
35.67M
92.18%
-2.09M
2023Q4
759
36.33M
94.13%
-67.98K
2023Q3
737
35.15M
91.46%
-2.09M
2023Q2
719
36.20M
94.64%
-1.94M
2023Q1
681
37.31M
97.62%
-964.82K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Fidelity Management & Research Company LLC
4.95M
12.77%
+91.48K
+1.88%
Mar 31, 2025
The Vanguard Group, Inc.
3.67M
9.47%
+24.73K
+0.68%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
3.53M
9.11%
+30.07K
+0.86%
Mar 31, 2025
T. Rowe Price Associates, Inc.
1.18M
3.04%
-58.36K
-4.73%
Mar 31, 2025
State Street Global Advisors (US)
1.20M
3.09%
-5.56K
-0.46%
Mar 31, 2025
Elsesser (Adam)
960.02K
2.48%
+24.15K
+2.58%
Jun 25, 2025
Baillie Gifford & Co.
689.00K
1.78%
-41.24K
-5.65%
Mar 31, 2025
RTW Investments L.P.
862.77K
2.23%
+320.00
+0.04%
Mar 31, 2025
Fidelity Institutional Asset Management
894.92K
2.31%
-70.23K
-7.28%
Mar 31, 2025
Champlain Investment Partners, LLC
869.92K
2.25%
-626.03K
-41.85%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Nome
Proporção
Sem dados
Dividendo
Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI